|
Platinum chemotherapy Clinical Trials
3 actively recruiting trials across 2 locations
Pipeline
Phase 2: 1Phase 3: 1Phase 1/2: 1
Top Sponsors
- Ellipses Pharma1
- Daiichi Sankyo1
- Akeso1
Indications
- Cancer3
- Lung Cancer2
- Advanced Non Small Cell Lung Cancer (NSCLC)1
- Advanced Solid Tumor1
- NSCLC1
Other1 trial
Anchorage, Alaska1 trial
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
Alaska Oncology & Hematology, LLC
Phase 3
Los Angeles, California1 trial
A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignancies
David Geffen School of Medicine at UCLA
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.